company background image
BDX

BCAL Diagnostics ASX:BDX Stock Report

Last Price

AU$0.06

Market Cap

AU$12.7m

7D

0%

1Y

-42.9%

Updated

28 Jan, 2023

Data

Company Financials

BDX Stock Overview

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer.

BDX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

BCAL Diagnostics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BCAL Diagnostics
Historical stock prices
Current Share PriceAU$0.06
52 Week HighAU$0.15
52 Week LowAU$0.059
Beta0
1 Month Change0%
3 Month Change-9.09%
1 Year Change-42.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO-76.00%

Recent News & Updates

Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Apr 07
Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Recent updates

Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Apr 07
Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Dec 23
Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Shareholder Returns

BDXAU BiotechsAU Market
7D0%-1.4%0.6%
1Y-42.9%11.8%3.5%

Return vs Industry: BDX underperformed the Australian Biotechs industry which returned 11.8% over the past year.

Return vs Market: BDX underperformed the Australian Market which returned 3.5% over the past year.

Price Volatility

Is BDX's price volatile compared to industry and market?
BDX volatility
BDX Average Weekly Movementn/a
Biotechs Industry Average Movement9.1%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: Insufficient data to determine BDX's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine BDX's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aJohn Hurrellhttps://www.bcaldiagnostics.com

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient’s body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

BCAL Diagnostics Limited Fundamentals Summary

How do BCAL Diagnostics's earnings and revenue compare to its market cap?
BDX fundamental statistics
Market CapAU$12.69m
Earnings (TTM)-AU$3.39m
Revenue (TTM)AU$718.67k

17.7x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BDX income statement (TTM)
RevenueAU$718.67k
Cost of RevenueAU$0
Gross ProfitAU$718.67k
Other ExpensesAU$4.10m
Earnings-AU$3.39m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.016
Gross Margin100.00%
Net Profit Margin-471.08%
Debt/Equity Ratio0%

How did BDX perform over the long term?

See historical performance and comparison